Embedded Files
Grant Agency: Department of Biotechnology
2021 | Principal Investigator | 36 months
Artificial Intelligence for Affordable Screening and Prediction of Diabetic Retinopathy in the Framework of Big Data
Grant Agency: Heidelberg Engineering, Germany
2020 | Principal Investigator | 12 months
MPOD in Mactel and Non-centre involving Diabetic Macular Edema
Grant Agency: Mediwhale, Korea
2019 | Principal Investigator | 12 months
Validation of AI for Diabetic Retinopathy and Glaucoma
Grant Agency: Novartis, India
2019 | Principal Investigator | 12 months
Gut microbiome and Diabetic Retinopathy
Grant Agency: LCIF, USA
2018 | Principal Investigator | 36 months
Improving the Compliance of Patients with Diabetic Retinopathy for Regular Screening and Follow-up after Treatment of Sight Threatening Diabetic Retinopathy
Grant Agency: Microsoft, USA
2018 | Principal Investigator | 72 months
Validation for AI based DR detection algorithm
Grant Agency: Ministry of Health, Thailand
2017 | Principal Investigator | 24 months
TIGER (Thailand India Google Eye Research) study
Grant Agency: India-U.S. Collaborative Vision Research Program R01 and DBT
2017 | Co-Principal Investigator | 48 months
Unraveling the genetic architecture of Diabetic Retinopathy in South India
Grant Agency: Medical Research council UK
2017 | Co-Principal Investigator | Oct 2018 - ongoing
Increasing eye research capacity and capabilities to tackle the burden of blindness in India: an interdisciplinary collaborative research-based approach between the United Kingdom and India
Grant Agency: Google, Mountain View, US
2015 | Principal Investigator | 36 months
Automated diagnosis of Diabetic Retinopathy
Grant Agency: Anglia Ruskin University
2014 | Co-Principal Investigator | 24 months
Auditory impairments in people with Low vision
Grant Agency: Sight savers International
2007 | Co-Principal Investigator | 24 months
Modelling the need for diabetic retinopathy screening in India (Collaboration with London School of Hygine)
Grant Agency: RD TATA trust
2007 | Principal Investigator | 36 months
Sankara Nethralaya – Diabetic Retinopathy Project, Rural Epidemiology Study II, Urban Epidemiology Study III
Grant Agency: World Diabetes Foundation, Denmark
2005 | Principal Investigator | 60 months
Telescreening for Diabetic Retinopathy
Grant Agency: Eli Lily and Company
2004 | Co-Principal Investigator | 24 months
Double Masked Placebo Controlled Parallel Randomized Phase III Study Comparing 32mg/day Ruboxistaurin with placebo for the reduction of Centre Threatening DME in patients with non-proliferative Diabetic Retinopathy and without centre threatening DME
Google Sites
Report abuse